Cargando…

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Growth hormone (GH) has been used for over 35 years, and its safety and efficacy has been studied extensively. Experimental studies showing the permissive role of GH/insulin-like growth factor 1 (IGF-I) in carcinogenesis have raised concerns regarding the safety of GH replacement in children and adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Boguszewski, Margaret C S, Boguszewski, Cesar L, Chemaililly, Wassim, Cohen, Laurie E, Gebauer, Judith, Higham, Claire, Hoffman, Andrew R, Polak, Michel, Yuen, Kevin C J, Alos, Nathalie, Antal, Zoltan, Bidlingmaier, Martin, Biller, Beverley M K, Brabant, George, Choong, Catherine S Y, Cianfarani, Stefano, Clayton, Peter E, Coutant, Regis, Cardoso-Demartini, Adriane A, Fernandez, Alberto, Grimberg, Adda, Guðmundsson, Kolbeinn, Guevara-Aguirre, Jaime, Ho, Ken K Y, Horikawa, Reiko, Isidori, Andrea M, Jørgensen, Jens Otto Lunde, Kamenicky, Peter, Karavitaki, Niki, Kopchick, John J, Lodish, Maya, Luo, Xiaoping, McCormack, Ann I, Meacham, Lillian, Melmed, Shlomo, Mostoufi Moab, Sogol, Müller, Hermann L, Neggers, Sebastian J C M M, Aguiar Oliveira, Manoel H, Ozono, Keiichi, Pennisi, Patricia A, Popovic, Vera, Radovick, Sally, Savendahl, Lars, Touraine, Philippe, van Santen, Hanneke M, Johannsson, Gudmundur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066587/
https://www.ncbi.nlm.nih.gov/pubmed/35319491
http://dx.doi.org/10.1530/EJE-21-1186